Revolution Medicines, Inc. is 3.8x more valuable than QIAGEN N.V. by market capitalization ($30.74 B vs $8.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | QGEN | RVMD |
|---|---|---|
| Market cap | $8.03 B | $30.74 B |
| US-listed rank | #1070 | #453 |
| Revenue (latest FY) | $2.09B | $0.00 |
| Net income (latest FY) | $424.88M | -$1.13B |
| Net margin | 20.3% | - |
| P/E (trailing FY) | 18.9 | - |
| SEC filings | 471 | 782 |
Revolution Medicines, Inc. is 3.8x more valuable than QIAGEN N.V. by market capitalization ($30.74 B vs $8.03 B).
In their latest fiscal years, QIAGEN N.V. reported $2.09B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: QIAGEN N.V. and Revolution Medicines, Inc., or browse the full rankings.